ABT-239

SynDRA canonical compound SYN1951845 — structure-anchored drug synonym record

Clinical phase	Phase 1
Primary target(s)	HRH1 \| HRH2 \| HRH3
Mechanism of action	histamine receptor antagonist

All known targets

HRH1
HRH2
HRH3

Mechanisms of action (all sources)

histamine receptor antagonist

Cross-references

Synonyms

4-[2-[2-(2-methylpyrrolidin-1-yl)ethyl]benzofuran-5-yl]benzonitrile

Look up ABT-239 in the interactive SynDRA portal →